Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 159.90K | 160.60K | 622.20K | 627.60K | 780.90K |
| Total Depreciation and Amortization | 895.80K | 900.10K | 778.50K | 785.20K | 834.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 709.90K | 713.30K | -253.00K | -255.20K | 423.00K |
| Change in Net Operating Assets | 66.40K | 66.80K | -133.50K | -134.60K | 748.50K |
| Cash from Operations | 1.83M | 1.84M | 1.01M | 1.02M | 2.79M |
| Capital Expenditure | -822.10K | -826.10K | -121.50K | -122.50K | -434.30K |
| Sale of Property, Plant, and Equipment | 7.50K | 7.50K | -- | -- | 73.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.00K | -8.00K | -971.50K | -980.00K | -375.90K |
| Cash from Investing | -822.60K | -826.60K | -1.09M | -1.10M | -736.90K |
| Total Debt Issued | 21.68M | 21.68M | 23.46M | 23.46M | 16.50M |
| Total Debt Repaid | -21.75M | -21.75M | -24.69M | -24.69M | -16.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.50K | -11.50K | -1.09M | -1.10M | -1.49M |
| Other Financing Activities | -1.49M | -1.49M | -268.50K | -268.50K | -2.25M |
| Cash from Financing | -227.60K | -228.70K | -1.30M | -1.31M | -1.80M |
| Foreign Exchange rate Adjustments | 11.50K | 11.60K | 100.00 | 100.00 | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 793.40K | 797.20K | -1.38M | -1.39M | 252.90K |